AUROBINDO PHARMA
Sector : Pharmaceuticals and health care | Largecap | BSE
Here's the live share price of Aurobindo Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.9₹ -10.15
As on Sep 19, 2025, 4:01 PM IST
Aurobindo Pharma Price Performance
Today's LowToday's High
₹1,116.80₹1,137.00
₹1,118.35
52 Weeks' Low52 Weeks' High
₹994.35₹1,560.30
₹1,118.35
Open Price
₹1,131.90
Prev. Close
₹1,128.50
Volume
29,943
Over the last 5 years, the share price of Aurobindo Pharma has gained 7.17% CAGR. Over the past year, the corresponding return has been -26.78%.
Aurobindo Pharma’s current P/E of 19.15x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Aurobindo Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | 2.17 | 6.92 | 2.02 | -4.77 | -25.29 | 29.10 | 7.17 |
| Sun Pharmaceutical Industries | 2.46 | 1.31 | -0.48 | -5.37 | -11.23 | 23.72 | 26.88 |
| Divi's Laboratories | 2.72 | 3.09 | -6.06 | 6.30 | 13.58 | 19.59 | 14.40 |
| Cipla | 0.10 | 1.91 | 5.00 | 4.12 | -3.91 | 15.04 | 15.46 |
| Torrent Pharmaceuticals | 2.14 | -0.56 | 14.95 | 12.77 | 5.21 | 35.04 | 21.92 |
| Dr. Reddy's Laboratories | 0.55 | 6.26 | -0.14 | 11.54 | 1.00 | 17.31 | 5.19 |
| Mankind Pharma | 3.11 | 6.16 | 16.21 | 18.43 | 4.43 | 23.16 | 13.31 |
| Zydus Lifesciences | -0.75 | 5.49 | 8.36 | 13.12 | -1.74 | 42.32 | 21.23 |
| Lupin | 0.75 | 6.06 | 5.71 | -1.29 | -4.38 | 47.48 | 14.61 |
| Alkem Laboratories | 2.04 | 3.01 | 16.36 | 13.37 | -8.69 | 19.64 | 14.17 |
| Abbott India | -1.82 | -6.80 | -3.58 | 0.73 | 7.74 | 20.47 | 13.85 |
| Glenmark Pharmaceuticals | -2.16 | 8.41 | 27.35 | 41.03 | 28.25 | 77.84 | 34.53 |
| Laurus Labs | 4.19 | 6.58 | 43.34 | 54.49 | 99.74 | 22.52 | 26.75 |
| Biocon | 1.26 | 2.88 | 5.15 | 8.42 | 1.12 | 8.42 | -2.92 |
| Anthem Biosciences | 1.98 | 1.05 | 16.36 | 16.36 | 16.36 | 5.18 | 3.08 |
| GlaxoSmithKline Pharmaceuticals | -1.38 | -1.75 | -14.62 | -4.34 | 0.95 | 24.71 | 10.06 |
| Ipca Laboratories | 6.86 | 2.63 | 2.36 | 0.32 | -2.00 | 17.89 | 6.17 |
| Cohance Lifesciences | -7.40 | 1.68 | -7.76 | -23.89 | -25.17 | 25.51 | 19.13 |
| Gland Pharma | 0.04 | 4.00 | 17.43 | 27.17 | 12.58 | -3.43 | 2.12 |
| Ajanta Pharma | -1.07 | -4.85 | -1.33 | -2.88 | -18.53 | 26.20 | 19.22 |
Over the last one year, Aurobindo Pharma has declined 25.29% compared to peers like Sun Pharmaceutical Industries (-11.23%), Divi's Laboratories (13.58%), Cipla (-3.91%). From a 5 year perspective, Aurobindo Pharma has underperformed peers relative to Sun Pharmaceutical Industries (26.88%) and Divi's Laboratories (14.40%).
Aurobindo Pharma Financials
Aurobindo Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,098.22 | 1,102.45 |
| 10 | 1,070.54 | 1,086.55 |
| 20 | 1,054.65 | 1,075.53 |
| 50 | 1,088.73 | 1,087.17 |
| 100 | 1,128.02 | 1,114.29 |
| 200 | 1,155.68 | 1,150.55 |
Aurobindo Pharma Share Holding Pattern
In the latest quarter, Aurobindo Pharma remained same as its previous close in promoter holding, while DII stake increased to 26.93%, FII holding fell to 14.38%, and public shareholding moved up to 6.88% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Aurobindo Pharma Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| HDFC Mid-Cap Opportunities Fund - Regular Plan | 1,33,44,745 | 1.65 | 1,371.71 |
| Quant Mid Cap Fund | 59,69,000 | 7.38 | 613.55 |
| SBI Large & Midcap Fund | 56,00,000 | 1.73 | 575.62 |
| Quant ELSS Tax Saver Fund | 51,74,277 | 4.67 | 531.86 |
| Quant Active Fund | 42,94,483 | 4.8 | 441.43 |
| ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 39,12,690 | 6.53 | 402.19 |
| Mirae Asset Large & Midcap Fund | 38,74,334 | 1 | 398.24 |
| ICICI Prudential India Opportunities Fund | 37,11,301 | 1.28 | 381.48 |
| ICICI Prudential Bluechip Fund | 32,78,275 | 0.47 | 336.97 |
| ICICI Prudential Value Discovery Fund | 32,30,588 | 0.62 | 332.07 |
Aurobindo Pharma Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Aurobindo Pharma Options
Aurobindo Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 19, 2025, 6:54 PM IST | Aurobindo Pharma - Fire Accident At Unit-IV Of APL Healthcare Limited, A Wholly Owned Subsidiary Of The Company |
| Sep 19, 2025, 3:49 PM IST | Aurobindo Pharma - Curateq Biologics Announces Successful Completion Of Phase 3 Clinical Study For Denosumab Biosimilar. |
| Sep 12, 2025, 7:55 PM IST | Aurobindo Pharma - Clarification On Significant Volume Movement In Company'S Shares |
| Sep 12, 2025, 6:51 PM IST | Aurobindo Pharma - Clarification sought from Aurobindo Pharma Ltd |
| Sep 11, 2025, 11:03 PM IST | Aurobindo Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
About Aurobindo Pharma
Aurobindo Pharma Ltd. is a Public Limited Listed company incorporated on 26/12/1986 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24239TG1986PLC015190 and registration number is 015190. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 10933.30 Cr. and Equity Capital is Rs. 58.08 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No.2, Maitri Vihar, Hyderabad Telangana 500038
- Contact
Management
- Mr. M Ramasubramanian KumarNon Exe.Chairman&Ind.Director
- Mr. K Nithyananda ReddyVice Chairman & Mng.Director
- Mr. M Madan Mohan ReddyWhole Time Director
- Mr. P V Ramprasad ReddyNon Executive Director
- Dr. Satakarni MakkapatiNon Executive Director
- Mr. P Sarath Chandra ReddyNon Executive Director
- Mr. Girish P VanvariIndependent Director
- Mr. Santanu MukherjeeIndependent Director
- Dr. Deepali Pant JoshiIndependent Director
FAQs on Aurobindo Pharma Share Price
What is the share price of Aurobindo Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Aurobindo Pharma is ₹1,118.35 as on Sep 19, 2025.
What kind of stock is Aurobindo Pharma?
The Aurobindo Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
What is the Market Cap of Aurobindo Pharma?
The market cap of Aurobindo Pharma is ₹64,953.95 Cr as on Sep 19, 2025.
What are today's High and Low prices of Aurobindo Pharma?
Today’s highest and lowest price of Aurobindo Pharma are ₹1,137.00 and ₹1,116.80.
What are the 52 Week High and 52 Week Low of Aurobindo Pharma?
The 52-week high/low is the highest and lowest price at which Aurobindo Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Aurobindo Pharma is ₹1,560.30 and 52-week low of Aurobindo Pharma is ₹994.35 as on Sep 19, 2025.
How has the Aurobindo Pharma performed historically in terms of returns?
The Aurobindo Pharma has shown returns of -0.9% over the past day, 2.57% for the past month, 3.24% over 3 months, -26.78% over 1 year, 29.1% across 3 years, and 7.17% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Aurobindo Pharma?
P/E ratio of and PB ratio of Aurobindo Pharma are 19.15 and 2.10 on Sep 19, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data